Aegis capital corp. acted as sole bookrunner on a $10 million underwritten public offering for glucotrack, inc. (nasdaq: gctk)

New york, ny / accesswire / april 17, 2023 / aegis capital corp. acted as sole bookrunner on a $10 million underwritten public offering for glucotrack, inc. (nasdaq:gctk). about glucotrack, inc. glucotrack, inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in israel and internationally.
GCTK Ratings Summary
GCTK Quant Ranking